首页> 美国卫生研究院文献>BMJ Open Gastroenterology >Interference with the lower gut–liver axis induces remission of primary sclerosing cholangitis in a patient with ulcerative colitis
【2h】

Interference with the lower gut–liver axis induces remission of primary sclerosing cholangitis in a patient with ulcerative colitis

机译:溃疡性结肠炎患者对下肠肝轴的干扰可导致原发性硬化性胆管炎的缓解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The gut–liver axis describes the complex interactions between gut microbiota, the small and large bowel, the immune system and the liver. Current evidence associates abnormalities within the gut–liver axis with liver disease such as primary sclerosing cholangitis (PSC). PSC is believed to be an immune-mediated disease though the exact mechanism of its pathogenesis remains unknown. Here, we report a case of a 66 -year-old woman with treatment-resistant ulcerative colitis and PSC which continued to be active following subtotal colectomy. Interestingly, her PSC achieved full remission after proctectomy for treatment-resistant proctitis in the rectal stump. This case report supports existing hypotheses that PSC is an immune-mediated disease triggered by antigens within the gut. More notably, it suggests the yet unidentified pathogens may be localised to the lower gastrointestinal tract including the rectum.
机译:肠肝轴描述了肠道菌群,大小肠,免疫系统和肝脏之间的复杂相互作用。目前的证据将肠肝轴内的异常与肝脏疾病(例如原发性硬化性胆管炎(PSC))联系起来。尽管PSC的确切发病机理尚不清楚,但仍被认为是一种免疫介导的疾病。在此,我们报告了一名66岁女性,其具有治疗抵抗性溃疡性结肠炎和PSC,在大肠切除术后仍继续活跃。有趣的是,由于直肠残端的治疗性直肠炎,直肠切除术后她的PSC完全缓解。该病例报告支持现有的假设,即PSC是由肠道内抗原触发的免疫介导的疾病。更值得注意的是,这表明尚未确定的病原体可能位于包括胃肠道在内的下消化道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号